Maravai LifeSciences Holdings, Inc.
MRVI
$4.15
-$0.14-3.26%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -41.79% | -33.01% | -57.87% | -53.44% | -49.25% |
| Total Receivables | 17.27% | -33.81% | -21.94% | -28.98% | -27.92% |
| Inventory | -18.71% | -19.14% | -10.08% | -5.33% | -0.15% |
| Prepaid Expenses | -7.91% | -20.29% | -33.38% | -10.30% | -22.92% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -33.10% | -30.97% | -52.01% | -47.51% | -43.66% |
|
|
|||||
| Total Current Assets | -33.10% | -30.97% | -52.01% | -47.51% | -43.66% |
| Net Property, Plant & Equipment | -11.72% | -12.11% | -3.60% | -1.68% | 2.97% |
| Long-term Investments | -19.05% | -19.05% | -24.66% | -60.30% | -50.96% |
| Goodwill | -19.05% | -19.05% | -24.66% | -60.30% | -50.96% |
| Total Other Intangibles | -27.40% | -22.27% | -7.92% | -6.84% | -6.79% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -30.13% | -63.87% | -18.91% | -18.09% | -23.21% |
| Total Assets | -25.69% | -23.57% | -33.56% | -38.04% | -33.56% |
|
|
|||||
| Total Accounts Payable | -10.39% | -75.66% | -15.76% | -8.06% | 15.79% |
| Total Accrued Expenses | -28.53% | -19.33% | 15.76% | -8.88% | 15.68% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -8.88% | 3.56% | 7.69% | 7.34% | 29.58% |
| Total Finance Division Other Current Liabilities | -- | 58.45% | -40.61% | 21.33% | -30.12% |
| Total Other Current Liabilities | -- | 58.45% | -40.61% | 21.33% | -30.12% |
| Total Current Liabilities | -32.52% | -21.16% | -2.64% | 1.65% | 7.01% |
|
|
|||||
| Total Current Liabilities | -32.52% | -21.16% | -2.64% | 1.65% | 7.01% |
| Long-Term Debt | -18.63% | -1.43% | -44.34% | -44.22% | -44.10% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -14.12% | -11.47% | -20.98% | -19.39% | -15.05% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -15.67% | -77.97% | 17.72% | 249.50% | -12.05% |
| Total Liabilities | -19.87% | -7.70% | -37.25% | -36.09% | -35.63% |
|
|
|||||
| Common Stock & APIC | 8.12% | 9.40% | 11.77% | 13.50% | 38.21% |
| Retained Earnings | -94.24% | -92.82% | -72.58% | -73.18% | -59.46% |
| Treasury Stock & Other | 43.83% | -- | -- | -- | -- |
| Total Common Equity | -29.62% | -34.71% | -28.89% | -39.15% | -26.80% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -29.62% | -34.71% | -28.89% | -39.15% | -26.80% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -31.41% | -36.36% | -30.44% | -40.46% | -37.38% |
| Total Equity | -30.40% | -35.43% | -29.56% | -39.73% | -31.79% |
|
|
|||||